Table of Contents

Articles

• Perspectives in Cancer Research

  Many Growth Factors May Not Be Growth Factors

  Richmond T. Prehn

  Cancer Res February 1 1992 52 (3) 501-507;

  
  
• Articles

  Prolonged Inhibition by X-Rays of DNA Synthesis in Cells Obtained by Transformation of Primary Rat Embryo Fibroblasts with Oncogenes H-ras and v-myc

  Ya Wang and George Iliakis

  Cancer Res February 1 1992 52 (3) 508-514;

  
  
• Articles

  The Human Prostatic Carcinoma Cell Line LNCaP Expresses Biologically Active, Specific Receptors for 1α,25-Dihydroxyvitamin D₃

  Gary J. Miller, Gary E. Stapleton, Janet A. Ferrara, M. Scott Lucia, Stephen Pfister, Tammy E. Hedlund and Prakash Upadhya

  Cancer Res February 1 1992 52 (3) 515-520;

  
  
• Articles

  Pediatric Phase I Trial, Pharmacokinetic Study, and Limited Sampling Strategy for Piritrexim Administered on a Low-Dose, Intermittent Schedule

  Peter C. Adamson, Frank M. Balis, James Miser, Carola Arndt, Robert J. Wells, Andrea Gillespie, Leslie Aronson, John S. Penta, Neil J. Clendeninn and David G. Poplack

  Cancer Res February 1 1992 52 (3) 521-524;

  
  
• Articles

  Overexpression of Human Topoisomerase I in Baby Hamster Kidney Cells: Hypersensitivity of Clonal Isolates to Camptothecin

  Knut R. Madden and James J. Champoux

  Cancer Res February 1 1992 52 (3) 525-532;

  
  
• Articles

  Cellular Elimination of 2′,2′-Difluorodeoxycytidine 5′-Triphosphate: A Mechanism of Self-Potentiation

  Volker Heinemann, Yi-Zheng Xu, Sherri Chubb, Alina Sen, Larry W. Hertel, Gerald B. Grindey and William Plunkett

  Cancer Res February 1 1992 52 (3) 533-539;

  
  
• Articles

  Platinum Anticancer Drugs Modulate P-450 mRNA Levels and Differentially Alter Hepatic Drug and Steroid Hormone Metabolism in Male and Female Rats

  Gerald A. LeBlanc, Scott S. Sundseth, Georg F. Weber and David J. Waxman

  Cancer Res February 1 1992 52 (3) 540-547;

  
  
• Articles

  Activation and Growth of Murine Tumor-specific T-Cells Which Have in Vivo Activity with Bryostatin 1

  Todd M. Tuttle, Thomas H. Inge, Kevin P. Bethke, Carl W. McCrady, George R. Pettit and Harry D. Bear

  Cancer Res February 1 1992 52 (3) 548-553;

  
  
• Articles

  Endothelin-1 Gene Expression and Biosynthesis in Human Endometrial HEC-1A Cancer Cells

  Katherine Economos, Paul C. MacDonald and M. Linette Casey

  Cancer Res February 1 1992 52 (3) 554-557;

  
  
• Articles

  Mutation(s) of the Thymidylate Synthase Gene of Human Adenocarcinoma Cells Causes a Thymidylate Synthase-negative Phenotype That Can Be Attenuated by Exogenous Folates

  Peter J. Houghton, Atiqur Rahman, Cindy L. Will, Bruce J. Dolnick and Janet A. Houghton

  Cancer Res February 1 1992 52 (3) 558-565;

  
  
• Articles

  Surface Immunoglobulin-mediated Signal Transduction Involves Rapid Phosphorylation and Activation of the Protooncogene Product Raf-1 in Human B-Cells

  Toshiharu Tamaki, Yuzuru Kanakura, Akira Kuriu, Hirokazu Ikeda, Hideki Mitsui, Hirosuke Yagura, Itaru Matsumura, Brian Druker, James D. Griffin, Yoshio Kanayama and Takeshi Yonezawa

  Cancer Res February 1 1992 52 (3) 566-570;

  
  
• Articles

  Basic Fibroblast Growth Factor in Human Prostate Cancer Cells

  Takahisa Nakamoto, Chawnshang Chang, Ankun Li and Gerald W. Chodak

  Cancer Res February 1 1992 52 (3) 571-577;

  
  
• Articles

  Hormone Levels in Vegetarian and Nonvegetarian Teenage Girls: Potential Implications for Breast Cancer Risk

  Victoria W. Persky, Robert T. Chatterton, Linda V. Van Horn, Mark D. Grant, Patricia Langenberg and Joy Marvin

  Cancer Res February 1 1992 52 (3) 578-583;

  
  
• Articles

  Blood Flow in Six Human Melanoma Xenograft Lines with Different Growth Characteristics

  Heidi Lyng, Arne Skretting and Einar K. Rofstad

  Cancer Res February 1 1992 52 (3) 584-592;

  
  
• Articles

  Heterogeneity of Progesterone Receptor Content and Remodeling by Tamoxifen Characterize Subpopulations of Cultured Human Breast Cancer Cells: Analysis by Quantitative Dual Parameter Flow Cytometry

  Mark L. Graham II, Jeffrey A. Smith, Phillip B. Jewett and Kathryn B. Horwitz

  Cancer Res February 1 1992 52 (3) 593-602;

  
  
• Articles

  Clinical Pharmacokinetics of the Anthrapyrazole CI-941: Factors Compromising the Implementation of a Pharmacokinetically Guided Dose Escalation Scheme

  M. A. Graham, D. R. Newell, B. J. Foster, L. A. Gumbrell, K. E. Jenns and A. H. Calvert

  Cancer Res February 1 1992 52 (3) 603-609;

  
  
• Articles

  Novel Compounds Inhibit Estrogen Formation and Action

  Claude Labrie, Céline Martel, Jean-Marc Dufour, Charles Lévesque, Yves Mérand and Fernand Labrie

  Cancer Res February 1 1992 52 (3) 610-615;

  
  
• Articles

  Examination of the Oncogenic Potential of a Tumor-associated Antigen, Intestinal Alkaline Phosphatase, in HeLa × Fibroblast Cell Hybrids

  Kathryn M. Latham and Eric J. Stanbridge

  Cancer Res February 1 1992 52 (3) 616-622;

  
  
• Articles

  Blocking Effect of Human Serum but not of Cerebrospinal Fluid on Ricin A Chain Immunotoxin Potentiation by Monensin or Carrier Protein-Monensin Conjugates

  Carola Candiani, Antonia Franceschi, Roberto Chignola, Marcella Pasti, Cristina Anselmi, Giuseppina Benoni, Giuseppe Tridente and Marco Colombatti

  Cancer Res February 1 1992 52 (3) 623-630;

  
  
• Articles

  The Chlorinated Pesticide Mirex Is a Novel Nonphorbol Ester-type Tumor Promoter in Mouse Skin

  Glenda J. Moser, Sharon A. Meyer and Robert C. Smart

  Cancer Res February 1 1992 52 (3) 631-636;

  
  
• Articles

  Improved Delivery of Radiolabeled Anti-B1 Monoclonal Antibody to Raji Lymphoma Xenografts by Predosing with Unlabeled Anti-B1 Monoclonal Antibody

  Donald J. Buchsbaum, Richard L. Wahl, Stephan D. Glenn, Daniel P. Normolle and Mark S. Kaminski

  Cancer Res February 1 1992 52 (3) 637-642;

  
  
• Articles

  Disruption of the APC Gene by a Retrotransposal Insertion of L1 Sequence in a Colon Cancer

  Yoshio Miki, Isamu Nishisho, Akira Horii, Yasuo Miyoshi, Joji Utsunomiya, Kenneth W. Kinzler, Bert Vogelstein and Yusuke Nakamura

  Cancer Res February 1 1992 52 (3) 643-645;

  
  
• Articles

  In Vivo Targeting of OV-TL 3 Immunoliposomes to Ascitic Ovarian Carcinoma Cells (OVCAR-3) in Athymic Nude Mice

  Ulla K. Nässander, Peter A. Steerenberg, Hilde Poppe, Gert Storm, Lambert G. Poels, Wim H. De Jong and Daan J. A. Crommelin

  Cancer Res February 1 1992 52 (3) 646-653;

  
  
• Articles

  Failure of RB1 to Reverse the Malignant Phenotype of Human Tumor Cell Lines

  Michelle M. Muncaster, Brenda L. Cohen, Robert A. Phillips and Brenda L. Gallie

  Cancer Res February 1 1992 52 (3) 654-661;

  
  
• Articles

  The Effect of Dietary Fat on the Rapid Development of Mammary Tumors Induced by 7,12-Dimethylbenz(a)anthracene in SENCAR Mice

  Susan M. Fischer, Claudio J. Conti, Mary Locniskar, Martha A. Belury, Regina E. Maldve, Marilyn L. Lee, Julius Leyton, Thomas J. Slaga and David H. Bechtel

  Cancer Res February 1 1992 52 (3) 662-666;

  
  
• Articles

  Individual Transforming Events in Long-Term Cell Culture of NIH 3T3 Cells as Products of Epigenetic Induction

  Bryan J. Ellison and Harry Rubin

  Cancer Res February 1 1992 52 (3) 667-673;

  
  
• Articles

  p53 Mutation and Loss of Heterozygosity on Chromosomes 17 and 10 during Human Astrocytoma Progression

  Dan Fults, Douglas Brockmeyer, Micam W. Tullous, Carolyn A. Pedone and Richard M. Cawthon

  Cancer Res February 1 1992 52 (3) 674-679;

  
  
• Articles

  Expression of Simple Epithelial Cytokeratins in Mouse Epidermal Keratinocytes Harboring Harvey ras Gene Alterations

  Margarita Diaz-Guerra, Sheena Haddow, Cristina Bauluz, Jose Luis Jorcano, Amparo Cano, Allan Balmain and Miguel Quintanilla

  Cancer Res February 1 1992 52 (3) 680-687;

  
  
• Articles

  Neoplastic Progression by EJ/ras at Different Steps of Transformation in Vitro of Human Uroepithelial Cells

  Carol I. Pratt, Chinghai Kao, Shi-Q. Wu, Kennedy W. Gilchrist, Ryoichi Oyasu and Catherine A. Reznikoff

  Cancer Res February 1 1992 52 (3) 688-695;

  
  
• Articles

  Reduced Growth Rate of Dimethylhydrazine-induced Colon Tumors in Rats

  Akira Tsunoda, Miki Shibusawa, Yuko Tsunoda, Naokuni Yasuda and Tadashi Koike

  Cancer Res February 1 1992 52 (3) 696-700;

  
  
• Articles

  Inhibition of Invasion and Metastasis in Cells Transfected with an Inhibitor of Metalloproteinases

  Yves A. DeClerck, Norma Perez, Hiroyuki Shimada, Thomas C. Boone, Keith E. Langley and Shirley M. Taylor

  Cancer Res February 1 1992 52 (3) 701-708;

  
  
• Articles

  Synthesis and Evaluation of Fluoromycin: A Novel Fluorescence-labeled Derivative of Talisomycin S_10b

  Jehangir S. Mistry, Jitesh P. Jani, Geoffrey Morris, Ratnakar B. Mujumdar, Ian J. Reynolds, Said M. Sebti and John S. Lazo

  Cancer Res February 1 1992 52 (3) 709-718;

  
  
• Articles

  Measurement of Thymidine Replacement in Patients with High Grade Gliomas, Head and Neck Tumors, and High Grade Sarcomas after Continuous Intravenous Infusions of 5-Iododeoxyuridine

  John A. Cook, Joseph Glass, Robert Lebovics, Hunt Bobo, Harvey Pass, Thomas F. DeLaney, Edward H. Oldfield, James B. Mitchell, Eli Glatstein and Thomas E. Goffman

  Cancer Res February 1 1992 52 (3) 719-725;

  
  
• Articles

  Recombinant Interleukin-2 and Lymphokine-activated Killer Cell Treatment of Advanced Bladder Cancer: Clinical Results and Immunological Effects

  Gregers Gautier Hermann, Poul Flemming Geertsen, Hans von der Maase, Kenneth Steven, Claus Andersen, Tage Hald and Jesper Zeuthen

  Cancer Res February 1 1992 52 (3) 726-733;

  
  
• Advances in Brief

  p53 Mutations in Non-Small Cell Lung Cancer in Japan: Association between Mutations and Smoking

  Hiroko Suzuki, Takashi Takahashi, Tetsuo Kuroishi, Motokazu Suyama, Yutaka Ariyoshi, Toshitada Takahashi and Ryuzo Ueda

  Cancer Res February 1 1992 52 (3) 734-736;

  
  
• Advances in Brief

  Protein-Tyrosine Phosphatase Expression in Pre-B Cell NALM-6

  Masaaki Adachi, Masuo Sekiya, Yoshiaki Arimura, Mutsuhiro Takekawa, Fumio Itoh, Yuji Hinoda, Kohzoh Imai and Akira Yachi

  Cancer Res February 1 1992 52 (3) 737-740;

  
  
• Advances in Brief

  Loss of Heterozygosity Affecting the p53, Rb, and mcc/apc Tumor Suppressor Gene Loci in Dysplastic and Cancerous Ulcerative Colitis

  Bruce D. Greenwald, Noam Harpaz, Jing Yin, Ying Huang, Yi Tong, Victoria L. Brown, Tim McDaniel, Carnell Newkirk, James H. Resau and Stephen J. Meltzer

  Cancer Res February 1 1992 52 (3) 741-745;

  
  
• Advances in Brief

  FLT4, a Novel Class III Receptor Tyrosine Kinase in Chromosome 5q33-qter

  Olga Aprelikova, Katri Pajusola, Juha Partanen, Elina Armstrong, Riitta Alitalo, Stacie K. Bailey, Jeannette McMahon, John Wasmuth, Kay Huebner and Kari Alitalo

  Cancer Res February 1 1992 52 (3) 746-748;

  
  
• Advances in Brief

  Altered Expression of Wild-Type p53 Tumor Suppressor Gene during Murine Epithelial Cell Transformation

  Kyung-An Han and Molly F. Kulesz-Martin

  Cancer Res February 1 1992 52 (3) 749-753;

  
  
• Articles

  Announcements

  Cancer Res February 1 1992 52 (3) 754-755;